Issuer positions
6
Reporting Owner Activity for Laura Hamill
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
Jazz Pharmaceuticals plc
Disclosed value
$856.4K
Recent activity
Available
- Owner positions from Forms 3/4/5
-
Reported position value
$856,356
Estimated from parsed Forms 3/4/5 when the filing discloses holding values.
Reported issuer count
6
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest reported position
Jazz Pharmaceuticals plc (JAZZ)
About $771.3K reported in parsed owner filings.
Latest owner filing
19 Sep 2025
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
- Verify the source filing before treating any owner position as current.
- Location
- Paradise Valley, AZ
- SEC signature
- /s/ John LaRocca, Attorney-in-Fact
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow Laura Hamill and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Laura Hamill
JAZZ
Forms 3/4/5
Jazz Pharmaceuticals plc
- Relationship
- Director
- Holdings value
- $771,297
- Past year net change
- Change %
- Report period
- 07 Aug 2025
ANAB
Forms 3/4/5
ANAPTYSBIO, INC
- Relationship
- Director
- Holdings value
- $85,059
- Past year net change
- Change %
- Report period
- 06 Jan 2023
YMAB
Forms 3/4/5
Y-mAbs Therapeutics, Inc.
- Relationship
- Director
- Holdings value
- $0
- Past year net change
- Change %
- Report period
- 16 Sep 2025
XLRN
Forms 3/4/5
ACCELERON PHARMA INC
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 19 Nov 2021
PRDS
Forms 3/4/5
PARDES BIOSCIENCES, INC.
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 31 Aug 2023
SCLX, SCLXW
Forms 3/4/5
Scilex Holding Co
- Relationship
- Director
- Holdings value
- Past year net change
- Change %
- Report period
- 17 Jan 2023
Insider Transactions Reported by Laura Hamill:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.